The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease

Movement Disorders

Volumn 23, Issue 4, 2008, Pages 599-602

  Paus, Sebastian ^a   Grünewald, Anne ^b   Klein, Christine ^b   Knapp, Michael ^a   Zimprich, Alexander ^c   Janetzky, Bernd ^d   Möller, Jens C ^e   Klockgether, Thomas ^a   Wüllner, Ullrich ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

DRD2; German competence network on PD; Levodopa; Parkinson's disease; Pharmacogenetics

Indexed keywords

BENSERAZIDE; BROMOCRIPTINE; CABERGOLINE; CARBIDOPA; DIHYDROERGOCRYPTINE; DOPAMINE 2 RECEPTOR; LEVODOPA; LISURIDE; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; TAQ POLYMERASE; DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DOSE CALCULATION; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PHARMACOGENETICS; PRIORITY JOURNAL; TREATMENT INDICATION; GENETICS; MIDDLE AGED; TREATMENT OUTCOME;

AGED; DOPAMINE AGONISTS; FEMALE; GENOTYPE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; TREATMENT OUTCOME;

EID: 47549087379     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21901     Document Type: Article

References (15)

1. Fahn S. Levodopa in the treatment of Parkinson's disease. J Neural Transm Suppl 2006;71:1-15.
2. Wang J, Liu ZL, Chen B. Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD Neurology 2001;56:1757-1759.
3. Kaiser R, Hofer A, Grapengiesser A, et al. L-dopa-induced adverse effects in PD and dopamine transporter gene polymorphism. Neurology 2003;60:1750-1755.
4. Makoff AJ, Graham JM, Arranz MJ, et al. Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease. Pharmacogenetics 2000;10:43-48.
5. Paus S, Seeger G, Brecht HM, et al. Association study of dopamine D2, D3, D4 receptor and scrotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease Mov Disord 2004;19:705-707.
6. Tan EK, Cheah SY, Fook-Chong S, et al. Functional COMT variant predicts response to high dose pyridoxine in Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet 2005;137:1-4.
7. Lee MS, Lyoo CH, Ulmanen I, Syvänen AC, Rinne JO. Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson's disease. Neurosci Lett 2001;298: 131-134.
8. Thompson J, Thomas N, Singleton A, et al. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997;7:479-484.
9. Pohjalainen T, Rinne JO, Nagren K, et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 1998;3:256-260.
10. Noble EP. The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes. Alcohol 1998;16:33-45.
11. Suzuki A, Mihara K, Kondo T, et al. The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients. Pharmacogenetics 2000;10:335-341.
12. Sakumoto N, Kondo T, Mihara K, Suzuki A, Yasui-Furukori N. Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia. Psychiatry Clin Neurosci 2007;61:174-180.
13. Oliveri RL, Annesi G, Zappia M, et al. The dopamine D2 receptor gene is a susceptibility locus for Parkinson's Disease. Mov Disord 2000;15:127-131.
14. Hobson DE, Lang AE, Martin WRW, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson's disease: a survey by the Canadian Movement Disorders Group. JAMA 2002;287:455-463.
15. Grandy DK, Zhang Y, Civelli O. PCR detection of the TaqA RFLP at the DRD2 locus. Hum Mol Genet 1993;2:2197.